Unusual 11 Midday Movers 02/23: (VVUS) (CTHR) (EXH) (SHLD) Higher; (GTI) (PVA) (GNK) Lower
Tweet
Share
E-mail
Get Alerts VVUS Hot Sheet
Join SI Premium – FREE
VIVUS's (Nasdaq: VVUS) 78.8% HIGHER; FDA advisory panel votes 20 for, 2 against safety of VIVUS's Qnexa. Click here to read the full report.
Charles & Colvard Ltd (NASDAQ: CTHR) 20.7% HIGHER; reported Q4 EPS of $0.09, versus $0.02 reported last year. Revenue for the quarter came in at $7.2 million, versus $3.5 million reported last year.
Exterran Holdings (NYSE: EXH) 18.3% HIGHER; reported Q4 EPS of ($1.06), which may not compare to the analyst estimate of ($0.46). Non-GAAP loss from continuing operations was $62.63 million. Revenue for the quarter came in at $702.9 million versus the consensus estimate of $634.93 million. announced today that J. Michael Anderson, Senior Vice President and Chief Financial Officer (CFO) of its managing general partner, has informed the Board of Directors that he intends to leave Exterran effective April 2, 2012. Anderson will be joining a privately held midstream company as its CFO. Exterran Partners also announced that David S. Miller has been appointed as Senior Vice President and CFO of Exterran GP LLC. Exterran Partners has agreed to acquire compression and processing assets from Exterran Holdings for consideration valued at approximately $184 million.
Sears Holding Corporation (NASDAQ: SHLD) 17.8% HIGHER; reported Q4 adjusted EPS of $0.54, $0.21 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.44 billion. The company also announced it intends to separate its Sears Hometown and Outlet Businesses and certain hardware stores through a proposed rights offering that is expected to raise approximately $400 million to $500 million. Sears also sold 11 full-line stores to General Growth Properties (NYSE: GGP) for $270 million.
Orexigen Therapeutics, Inc. (Nasdaq: OREX) 17.5% HIGHER; trading higher following news an FDA advisory panel has voted to back VIVUS's Qnexa diet pill.
Winner Medical Group (Nasdaq: WWIN) 17.5% HIGHER; gapped over the $3.25 level this morning, ran up past resistance at $3.50, and is now holding near the $3.75 level. Volume is extremely heavy today.
GrafTech International Ltd. (NYSE: GTI) 16% LOWER; reported Q4 EPS of $0.39, $0.09 better than the analyst estimate of $0.30. Revenue for the quarter came in at $348 million versus the consensus estimate of $363.42 million. The company forecasts 2012 EBITDA to be in the range of $250 million to $290 million and that the first quarter will be its weakest with EBITDA targeted to be in the range of $35 million to $45 million.
Penn Virginia (NYSE: PVA) 14.7% LOWER; reports Q4 loss of 61 cents per share, which compares to the Street estimate of a 27 cent per share loss, on sales of $80.5 million. The Street was looking for quarterly sales of $79.66 million. Sees FY12 product sales of $288-$319 million, which may not compare to the current Street estimate of $344.57 million.
Genco Shipping & Trading Limited (NYSE: GNK) 12.9% LOWER; announced the pricing of its public offering of common stock. The offering was made pursuant to Genco's registration statement (including a prospectus and related prospectus supplement for the offering). Total gross proceeds from the offering will be approximately $53.25 million.
HomeAway (NASDAQ: AWAY) 11.7% LOWER; reported Q4 EPS of $0.00, $0.09 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $58.5 million versus the consensus estimate of $58.28 million. Sees Q1 2012 revenue of $63.7-$64.0 million, versus the consensus of $65.7 million. Sees FY2012 revenue of $276-$280 million, versus the consensus of $283.95 million.
Polypore International (NYSE: PPO) 11.6% LOWER; reported Q4 EPS of $0.58, $0.02 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $191 million versus the consensus estimate of $196.36 million.
Charles & Colvard Ltd (NASDAQ: CTHR) 20.7% HIGHER; reported Q4 EPS of $0.09, versus $0.02 reported last year. Revenue for the quarter came in at $7.2 million, versus $3.5 million reported last year.
Exterran Holdings (NYSE: EXH) 18.3% HIGHER; reported Q4 EPS of ($1.06), which may not compare to the analyst estimate of ($0.46). Non-GAAP loss from continuing operations was $62.63 million. Revenue for the quarter came in at $702.9 million versus the consensus estimate of $634.93 million. announced today that J. Michael Anderson, Senior Vice President and Chief Financial Officer (CFO) of its managing general partner, has informed the Board of Directors that he intends to leave Exterran effective April 2, 2012. Anderson will be joining a privately held midstream company as its CFO. Exterran Partners also announced that David S. Miller has been appointed as Senior Vice President and CFO of Exterran GP LLC. Exterran Partners has agreed to acquire compression and processing assets from Exterran Holdings for consideration valued at approximately $184 million.
Sears Holding Corporation (NASDAQ: SHLD) 17.8% HIGHER; reported Q4 adjusted EPS of $0.54, $0.21 worse than the analyst estimate of $0.78. Revenue for the quarter came in at $12.5 billion versus the consensus estimate of $12.44 billion. The company also announced it intends to separate its Sears Hometown and Outlet Businesses and certain hardware stores through a proposed rights offering that is expected to raise approximately $400 million to $500 million. Sears also sold 11 full-line stores to General Growth Properties (NYSE: GGP) for $270 million.
Orexigen Therapeutics, Inc. (Nasdaq: OREX) 17.5% HIGHER; trading higher following news an FDA advisory panel has voted to back VIVUS's Qnexa diet pill.
Winner Medical Group (Nasdaq: WWIN) 17.5% HIGHER; gapped over the $3.25 level this morning, ran up past resistance at $3.50, and is now holding near the $3.75 level. Volume is extremely heavy today.
GrafTech International Ltd. (NYSE: GTI) 16% LOWER; reported Q4 EPS of $0.39, $0.09 better than the analyst estimate of $0.30. Revenue for the quarter came in at $348 million versus the consensus estimate of $363.42 million. The company forecasts 2012 EBITDA to be in the range of $250 million to $290 million and that the first quarter will be its weakest with EBITDA targeted to be in the range of $35 million to $45 million.
Penn Virginia (NYSE: PVA) 14.7% LOWER; reports Q4 loss of 61 cents per share, which compares to the Street estimate of a 27 cent per share loss, on sales of $80.5 million. The Street was looking for quarterly sales of $79.66 million. Sees FY12 product sales of $288-$319 million, which may not compare to the current Street estimate of $344.57 million.
Genco Shipping & Trading Limited (NYSE: GNK) 12.9% LOWER; announced the pricing of its public offering of common stock. The offering was made pursuant to Genco's registration statement (including a prospectus and related prospectus supplement for the offering). Total gross proceeds from the offering will be approximately $53.25 million.
HomeAway (NASDAQ: AWAY) 11.7% LOWER; reported Q4 EPS of $0.00, $0.09 worse than the analyst estimate of $0.09. Revenue for the quarter came in at $58.5 million versus the consensus estimate of $58.28 million. Sees Q1 2012 revenue of $63.7-$64.0 million, versus the consensus of $65.7 million. Sees FY2012 revenue of $276-$280 million, versus the consensus of $283.95 million.
Polypore International (NYSE: PPO) 11.6% LOWER; reported Q4 EPS of $0.58, $0.02 worse than the analyst estimate of $0.60. Revenue for the quarter came in at $191 million versus the consensus estimate of $196.36 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bernstein sees 'an entry point in our top-pick' chemical stock
- Value-focused retailer sees traffic momentum strengthen ahead of second quarter
- This stock is Wall Street's favorite retailer
Create E-mail Alert Related Categories
Special ReportsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
